069620.KS
Daewoong pharmaceutical Co.,Ltd
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 114,800.00
−7.49%Margins
Gross margin
51.6%
EBITDA margin
15.6%
EBIT margin
11.7%
Net margin
12.0%
FCF margin
-7.2%
18.4%
Return on equity
7.7%
Return on assets
9.6%
Return on invested capital
0.66x
Asset turnover
KRW 162.1B
Cash from operations
KRW 13.7K
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026